berberine has been researched along with chitosan in 32 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (3.13) | 18.2507 |
2000's | 1 (3.13) | 29.6817 |
2010's | 16 (50.00) | 24.3611 |
2020's | 14 (43.75) | 2.80 |
Authors | Studies |
---|---|
Fang, JY; Hsu, LR; Lin, HH; Tsai, CJ | 1 |
Li, J; Li, Y; Zhang, L; Zou, Q; Zuo, Y | 1 |
Chang, CH; Chen, TY; Hsu, YM; Huang, WY; Lai, CH; Lin, YH; Peng, SF; Wu, JY; Yao, YH | 1 |
Huang, Y; Jin, Y; Liu, YH; Zhang, ZR; Zhao, CY; Zhou, D; Zhu, X | 1 |
Huang, Y; Jin, Y; Song, YP; Zhang, ZR; Zhou, D; Zhu, X | 1 |
Chen, W; Fan, D; He, H; Meng, L; Miao, Y; Tang, X; Weng, Y; Yang, S | 1 |
Chang, CH; Chang, SJ; Chen, YS; Chou, SC; Chung, CC; Lin, JH; Lin, YH | 1 |
Don, TM; Lin, CW; Mi, FL; Wu, SJ | 1 |
Mi, FL; Wen, DY; Wu, JY; Wu, SJ; Yu, SH | 1 |
He, B; Liu, SQ; Peng, H; Yu, L; Zhao, Q; Zhou, Y | 1 |
Li, J; Li, Y; Zou, Q | 1 |
Bakoš, D; Dragúňová, J; Hnátová, M; Kabát, P; Klempaiová, M; Koller, J | 1 |
Deng, M; He, B; Li, Y; Liu, S; Ming, J; Zhou, Y | 1 |
Ding, D; Wang, Y; Wen, B; Yu, H; Zhang, J; Zhang, W; Zhang, Y; Zhao, L | 1 |
Chen, XM; Chen, Y; Gu, BH; Hou, XF; Liu, Y; Wu, X | 1 |
Ho, YC; Lin, YC; Lu, HT; Lu, KY; Mi, FL; Tsai, ML; Weng, SC | 1 |
El-Khordagui, LK; Ghareeb, DA; Nounou, MI; Sheweita, SA; Soudi, SA; Younis, LK | 1 |
Chen, D; Cheng, Z; Fan, X; Fang, L; Hou, X; Wang, Z; Zhang, W | 1 |
Abbaszadeh-Goudarzi, G; Ehterami, A; Garmabi, B; Khastar, H; Rahmati, M; Rezaei Kolarijani, N; Saberani, R; Salehi, M | 1 |
Ai, J; Darbemamieh, G; Khonakdar, HA; Mahya, S; Shirian, S; Shojae, S | 1 |
Chen, QL; Chu, JMT; Hu, YJ; Li, J; Linghu, KG; Wang, YT; Wong, GTC; Xiong, SH; Xiong, W; Yu, H; Zhao, GD | 1 |
Attar, F; Balali, E; Bloukh, SH; Derakhshankhah, H; Edis, Z; Falahati, M; Hao, X; Hua, L; Hussain, A; Khan, RH; Khan, S; Lin, Y; Nabi, F; Nemati, F; Sharifi, M; Ten Hagen, TLM; Zeinabad, HA | 1 |
Cai, L; Chen, W; Cui, D; Hou, X; Jiang, L; Tong, J; Xiong, B; Yao, H; Zhang, H | 1 |
Asoodeh, A; Ghobadi-Oghaz, N; Mohammadi, M | 1 |
Abdel-Wahhab, MA; Badawy, AM; Badawy, EA; El-Bana, MA; El-Dosoky, MA; Farrag, AE; Mahmoud, MA; Morsy, SM | 1 |
Li, D; Li, Y; Liu, H; Shi, M; Wang, Y; Zhang, X | 1 |
Chen, B; Chen, X; Hu, H; Jin, J; Liu, Z; Luo, F; Wang, L; Xu, H; Xu, M; Ye, F; Zhang, K; Zhang, Q; Zheng, S | 1 |
Chen, S; Fang, W; Gao, S; Hu, R; Lu, W; Nie, X; Sun, L; Zhang, Q | 1 |
Chen, H; Dong, Z; Li, N; Li, Y; Wang, J; Wu, C; Zhang, M; Zhang, Y; Zheng, T; Zou, P | 1 |
Haeri, A; Kamalinejad, M; Mortazavi, SA; Rabbani, S; Vaezi, H | 1 |
Bitaraf, FS; Hassani, MS; Mahami, S; Mehrabi, M; Omri, A; Salehi, M; Vahedi, H | 1 |
Ajithkumar, V; Rajan, M; Uma Maheswari, RT; Varalakshmi, P | 1 |
1 review(s) available for berberine and chitosan
Article | Year |
---|---|
A review of the berberine natural polysaccharide nanostructures as potential anticancer and antibacterial agents.
Topics: Anti-Bacterial Agents; Berberine; Biological Availability; Chitosan; Nanostructures | 2022 |
31 other study(ies) available for berberine and chitosan
Article | Year |
---|---|
Chitosan hydrogel as a base for transdermal delivery of berberine and its evaluation in rat skin.
Topics: Administration, Cutaneous; Animals; Berberine; Chitin; Chitosan; Drug Carriers; Drug Evaluation, Preclinical; Hydrogels; Male; Rats; Rats, Wistar; Skin | 1999 |
Antibiotic delivery system using nano-hydroxyapatite/chitosan bone cement consisting of berberine.
Topics: Anti-Bacterial Agents; Berberine; Bone Cements; Carbohydrates; Chitosan; Compressive Strength; Drug Delivery Systems; Durapatite; Materials Testing; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Nanostructures; Spectrophotometry, Infrared; Time Factors; X-Ray Diffraction | 2009 |
Development of novel nanoparticles shelled with heparin for berberine delivery to treat Helicobacter pylori.
Topics: Berberine; Cell Line; Cell Survival; Chitosan; Chromatography, High Pressure Liquid; Drug Delivery Systems; Fluorescence; Helicobacter pylori; Heparin; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Microscopy, Confocal; Nanoparticles; Particle Size; Solutions; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Static Electricity | 2011 |
pH-sensitive and mucoadhesive microspheres for duodenum-specific drug delivery system.
Topics: Adhesiveness; Berberine; Chitosan; Drug Delivery Systems; Duodenal Ulcer; Duodenum; Humans; Hydrogen-Ion Concentration; Hypromellose Derivatives; In Vitro Techniques; Intestinal Mucosa; Methylcellulose; Microscopy, Electron, Scanning; Microspheres; Tablets, Enteric-Coated | 2011 |
A novel microsphere with a three-layer structure for duodenum-specific drug delivery.
Topics: Animals; Anti-Bacterial Agents; Berberine; Chitosan; Drug Compounding; Drug Delivery Systems; Duodenum; Excipients; Microspheres; Mucins; Particle Size; Polymers; Rats; Rats, Wistar; Surface Properties; Swine | 2011 |
Enhancing effects of chitosan and chitosan hydrochloride on intestinal absorption of berberine in rats.
Topics: Animals; Area Under Curve; Berberine; Biological Availability; Chemistry, Pharmaceutical; Chitosan; Gastrointestinal Tract; Intestinal Absorption; Male; Rats; Rats, Wistar; Solubility; Solutions | 2012 |
Berberine-loaded targeted nanoparticles as specific Helicobacter pylori eradication therapy: in vitro and in vivo study.
Topics: Animals; Berberine; Chitosan; Drug Delivery Systems; Fucose; Helicobacter Infections; Helicobacter pylori; Heparin; Humans; Mice; Microscopy, Confocal; Nanoparticles | 2015 |
Delivery of berberine using chitosan/fucoidan-taurine conjugate nanoparticles for treatment of defective intestinal epithelial tight junction barrier.
Topics: Animals; Berberine; Caco-2 Cells; Cell Line; Chitosan; Coculture Techniques; Cytokines; Dextrans; Drug Carriers; Drug Delivery Systems; Fluorescein-5-isothiocyanate; Humans; Hydrogen-Ion Concentration; Intestinal Mucosa; Lipopolysaccharides; Mice; Nanoparticles; Nitric Oxide; Permeability; Polysaccharides; Taurine; Tight Junctions | 2014 |
Preparation of fucoidan-shelled and genipin-crosslinked chitosan beads for antibacterial application.
Topics: Administration, Oral; Anti-Bacterial Agents; Berberine; Chitosan; Cross-Linking Reagents; Delayed-Action Preparations; Escherichia coli; Escherichia coli Infections; Humans; Iridoids; Polysaccharides; Staphylococcal Infections; Staphylococcus aureus | 2015 |
In vivo anti-apoptosis activity of novel berberine-loaded chitosan nanoparticles effectively ameliorates osteoarthritis.
Topics: Animals; Apoptosis; Berberine; Cartilage, Articular; Chitosan; Chondrocytes; Cross-Linking Reagents; Cytokines; Drug Stability; Injections, Intra-Articular; Joints; Male; Nanoparticles; Osteoarthritis; Rats; Rats, Sprague-Dawley; Synovial Fluid | 2015 |
Preparation and characterization of vanillin-crosslinked chitosan therapeutic bioactive microcarriers.
Topics: Animals; Benzaldehydes; Berberine; Cell Line, Tumor; Chitosan; Cross-Linking Reagents; Delayed-Action Preparations; Diffusion; Drug Carriers; Drug Compounding; Drug Liberation; Emulsions; Humans; Implants, Experimental; Kinetics; Microspheres; Muscle, Skeletal; Osteoblasts; Particle Size; Rats; Rats, Sprague-Dawley | 2015 |
Cytotoxicity testing of a polyurethane nanofiber membrane modified with chitosan/β-cyclodextrin/berberine suitable for wound dressing application: evaluation of biocompatibility.
Topics: 3T3 Cells; Animals; Anti-Infective Agents; Bandages; Berberine; beta-Cyclodextrins; Biocompatible Materials; Cell Line; Cell Survival; Chitosan; Fibroblasts; Humans; Materials Testing; Mice; Nanofibers; Polyurethanes; Wound Healing | 2016 |
Sustained release effects of berberine-loaded chitosan microspheres on in vitro chondrocyte culture.
Topics: Animals; Apoptosis; Berberine; Caspase 3; Chitosan; Chondrocytes; Delayed-Action Preparations; Half-Life; Microscopy, Electron, Scanning; Microspheres; Osteoarthritis; Rats; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2017 |
Berberine Hydrochloride-Loaded Chitosan Nanoparticles Effectively Targets and Suppresses Human Nasopharyngeal Carcinoma.
Topics: Berberine; Chitosan; Humans; Nanoparticles; Nasopharyngeal Carcinoma | 2018 |
Sulfonato-β-Cyclodextrin Mediated Supramolecular Nanoparticle for Controlled Release of Berberine.
Topics: Berberine; beta-Cyclodextrins; Chitosan; Delayed-Action Preparations; Drug Carriers; Nanoparticles | 2018 |
A novel injectable in situ forming gel based on carboxymethyl hexanoyl chitosan/hyaluronic acid polymer blending for sustained release of berberine.
Topics: Apoptosis; Berberine; Cells, Cultured; Chitosan; Chondrocytes; Colloids; Delayed-Action Preparations; Gels; Humans; Hyaluronic Acid; Hydrogen-Ion Concentration; Nanoparticles; Nitroprusside; Particle Size | 2019 |
Protective effect of surface-modified berberine nanoparticles against LPS-induced neurodegenerative changes: a preclinical study.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Animals; Berberine; Brain; Chitosan; Glucose; Glutathione; Lipopolysaccharides; Liver; Male; Nanoparticles; Neurodegenerative Diseases; Neuroprotective Agents; Rats, Wistar | 2019 |
Novel mitochondrial targeting charge-reversal polysaccharide hybrid shell/core nanoparticles for prolonged systemic circulation and antitumor drug delivery.
Topics: Adenine; Animals; Antineoplastic Agents; Berberine; Cell Line; Chitosan; Curcumin; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Drug Liberation; Endocytosis; Humans; Hyaluronan Receptors; Hyaluronic Acid; Mice; Mice, Nude; Micelles; Mitochondria; Nanoparticles; Polymers; Polysaccharides | 2019 |
Improving sciatic nerve regeneration by using alginate/chitosan hydrogel containing berberine.
Topics: Alginates; Animals; Berberine; Chitosan; Humans; Hydrogels; Nerve Regeneration; Rats; Sciatic Nerve | 2021 |
Berberine loaded chitosan nanoparticles encapsulated in polysaccharide-based hydrogel for the repair of spinal cord.
Topics: Alginates; Animals; Berberine; Cells, Cultured; Chitosan; Drug Liberation; Endometrium; Female; Hydrogels; Male; Mesenchymal Stem Cells; Nanoparticles; Rats; Rats, Wistar; Spinal Cord; Spinal Cord Regeneration | 2021 |
Brij-functionalized chitosan nanocarrier system enhances the intestinal permeability of P-glycoprotein substrate-like drugs.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Berberine; Chitosan; Diabetic Nephropathies; Dogs; Drug Carriers; Fibrosis; Intestinal Mucosa; Kidney; Madin Darby Canine Kidney Cells; Male; Nanoparticles; Permeability; Polyethylene Glycols; Proof of Concept Study; Rats, Sprague-Dawley; Tight Junctions | 2021 |
A berberine hydrochloride-carboxymethyl chitosan hydrogel protects against Staphylococcus aureus infection in a rat mastitis model.
Topics: Animals; Anti-Bacterial Agents; Berberine; Chitosan; Female; Hydrogels; Mastitis; Microbial Sensitivity Tests; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Staphylococcus aureus | 2022 |
Fabrication, characterization and in vitro cell exposure study of zein-chitosan nanoparticles for co-delivery of curcumin and berberine.
Topics: Berberine; Chitosan; Curcumin; Nanoparticles; Particle Size; Zein | 2022 |
Synthesis and characterization of berberine-loaded chitosan nanoparticles for the protection of urethane-induced lung cancer.
Topics: Animals; bcl-2-Associated X Protein; Berberine; Caspase 9; Chitosan; Lung Neoplasms; Male; Mice; Nanoparticles; Urethane | 2022 |
Chitosan-Coated Solid Lipid Nano-Encapsulation Improves the Therapeutic Antiairway Inflammation Effect of Berberine against COPD in Cigarette Smoke-Exposed Rats.
Topics: Animals; Berberine; Chitosan; Cigarette Smoking; Cytokines; Humans; Inflammation; Lipids; Liposomes; Mice; Nanoparticles; Pulmonary Disease, Chronic Obstructive; Rats | 2022 |
Berberine coated biocomposite hemostatic film based alginate as absorbable biomaterial for wound healing.
Topics: Alginates; Animals; Anti-Bacterial Agents; Berberine; Biocompatible Materials; Chitosan; Hemostatics; Rats; Wound Healing | 2022 |
Mucus-Penetrating Alginate-Chitosan Nanoparticles Loaded with Berberine Hydrochloride for Oral Delivery to the Inflammation Site of Ulcerative Colitis.
Topics: Administration, Oral; Alginates; Berberine; Chitosan; Colitis, Ulcerative; Drug Carriers; Drug Delivery Systems; Humans; Inflammation; Mucus; Nanoparticles | 2022 |
Effect and Mechanism of Pharmaceutical Excipients on Berberine to Alleviate Ulcerative Colitis via Regulating Gut Microbiota.
Topics: Animals; Berberine; Chitosan; Claudin-2; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Eosine Yellowish-(YS); Excipients; Gastrointestinal Microbiome; Hematoxylin; Humans; Hypromellose Derivatives; Interleukin-6; Mice; Mice, Inbred C57BL; Occludin; Pectins; RNA, Ribosomal, 16S | 2022 |
Fabrication, in Vitro, and in Vivo Characterization of Mucoadhesive Berberine-Loaded Blended Wafers for Treatment of Chemotherapy-Induced Oral Mucositis.
Topics: Alginates; Animals; Antineoplastic Agents; Berberine; Chitosan; Fluorouracil; Hypromellose Derivatives; Rats; Spectroscopy, Fourier Transform Infrared; Stomatitis | 2022 |
pH-sensitive HPMCP-chitosan nanoparticles containing 5-aminosalicylic acid and berberine for oral colon delivery in a rat model of ulcerative colitis.
Topics: Animals; Berberine; Chitosan; Colitis, Ulcerative; Hydrogen-Ion Concentration; Mesalamine; Nanoparticles; Rats | 2023 |
CD44 tagged hyaluronic acid - chitosan liposome carrier for the delivery of berberine and doxorubicin into lung cancer cells.
Topics: Animals; Berberine; Caenorhabditis elegans; Chitosan; Doxorubicin; Drug Delivery Systems; Humans; Hyaluronan Receptors; Hyaluronic Acid; Liposomes; Lung Neoplasms; Nanoparticles | 2023 |